Macrocyclic inhibitors of kras for the treatment of cancer
US-2025257075-A1 · Aug 14, 2025 · US
in which the condensed system contains three hetero rings
in which the condensed system contains three hetero rings · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D498/12 |
| Official title | in which the condensed system contains three hetero rings |
| Display label | in which the condensed system contains three hetero rings |
| Total patents | 29 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Ras inhibitors
US-2025129097-A1 · Apr 24, 2025 · US
Methods and reagents for analyzing protein-protein interfaces
US-2024426833-A1 · Dec 26, 2024 · US
Nitrogen-containing tricyclic compound and pharmaceutical use thereof
US-2024417406-A1 · Dec 19, 2024 · US
Aromatic bridged ring amide derivatives for the treatment and prophylaxis of hepatitis b virus infection
US-2023286929-A1 · Sep 14, 2023 · US
A conjugation linker containing 2,3-diaminosuccinyl group
US-2023010108-A1 · Jan 12, 2023 · US
Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
US-11420981-B2 · Aug 23, 2022 · US
Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
US-2022119408-A1 · Apr 21, 2022 · US
Methods and reagents for analyzing protein-protein interfaces
US-2021285955-A1 · Sep 16, 2021 · US
Fused 1,4-diazepines as BET bromodomain inhibitors
US-11046709-B2 · Jun 29, 2021 · US
Macrocyclic proline derived hcv serine protease inhibitors
US-2020270303-A1 · Aug 27, 2020 · US
Process for the preparation of pure and stable crystalline Raltegravir potassium form 3
US-10752618-B2 · Aug 25, 2020 · US
Fused 1,4-Diazepines as BET Bromodomain Inhibitors
US-2019382415-A1 · Dec 19, 2019 · US
Process for the preparation of intermediate of dolutegravir
US-10442769-B2 · Oct 15, 2019 · US
Macrocyclic proline derived hcv serine protease inhibitors
US-2019263860-A1 · Aug 29, 2019 · US
Process for the preparation of pure and stable crystalline raltegravir potassium form 3
US-2019248773-A1 · Aug 15, 2019 · US
Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase
US-10189839-B2 · Jan 29, 2019 · US
Organic optoelectronic device and display apparatus
US-10115925-B2 · Oct 30, 2018 · US
Macrocyclic proline derived hcv serine protease inhibitors
US-2018162905-A1 · Jun 14, 2018 · US
Process for the preparation of intermediate of dolutegravir
US-2018148412-A1 · May 31, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D498/12?
- CPC C07D498/12 is the Cooperative Patent Classification code for “in which the condensed system contains three hetero rings.”
- How many patents are filed under CPC C07D498/12 (in which the condensed system contains three hetero rings)?
- Our database includes 29 publications tagged with this CPC code.
- Is patent activity under CPC C07D498/12 growing?
- Publication counts under this code: 2 in 2024 vs 2 in 2025 (latest complete years).